TKPHF News and Press, Takeda Pharmaceutical Co Ltd From 05/11/20

Quick Take ADC Therapeutics ( ADCT ) intends to raise $125 million from the sale of its common stock, per an amended registration statement . The company is advancing a pipeline of drug candidates for the treatment of blood cancers and solid tumors. ADCT is making a new attempt to go pu...

Takeda Teams Up with ProThera on IAIP Therapy Takeda Pharmaceutical Company Limited ( TAK ) announced inking a new deal with ProThera Biologics for the purpose of developing IAIP therapy. This plasma-derived therapy is intended to be used for treating acute inflammatory conditions. Both th...

The European Commission has extended Takeda Pharmaceutical's ( OTCPK:TKPHF ) current marketing authorization of ALUNBRIG (brigatinib) to include use as a monotherapy for the treatment of adult patients with anaplastic lymphoma kinase-positive (ALK+) advanced non-small cell lung cancer...

Evotec SE ( OTCPK:EVOTF )  announces that Evotec GT has established a long-term research alliance with Takeda ( OTCPK:TKPHF ) to support latter's research-stage gene therapy discovery programs. More news on: Evotec SE, Takeda Pharmaceutical Company Limited, Evotec SE, Healthcare...

Quick Take Keros Therapeutics ( KROS ) intends to raise $75 million from the sale of its common stock, per an amended S-1/A regulatory filing . The company is advancing a pipeline of drug treatment candidates for hematological and musculoskeletal diseases. KROS is entering Phase 2 trial...

New York City, NY:March 27, 2020 – Published via (Wired Release) – Recent Research and Future Market Potential of Bcl-2-Like Protein 1 Market in Global Industry: 2020 Research and New Innovations in Medical Devices Sector. The prime objective of the report is to offer updates and...

Codexis (NASDAQ: CDXS ) has signed a strategic collaboration and license agreement with Takeda Pharmaceutical ( OTCPK:TKPHF ) for the research and development of novel gene therapies for certain disease indications, including the treatment of lysosomal storage disorders and blood factor de...

Quick Take NLS Pharmaceutics ( NLSP ) has filed to raise $40.25 million in an IPO of its common stock, according to an F-1 registration statement . The company is advancing a pipeline of drug candidates for the treatment of various central nervous system disorders. NLSP expects to begin...

Takeda Pharmaceutical's ( OTCPK:TKPHF ) Millennium units is suing Sun Pharmaceuticals Industries ( OTCPK:SMPQY ), alleging a generic version of its Ninlaro cancer treatment proposed by Sun Pharma infringes on three of its patents. More news on: Takeda Pharmaceutical Company Limited, Sun Ph...

Takeda Pharmaceutical ( OTCPK:TKPHF ) gets a positive CHMP opinion recommending approval of the subcutaneous form of vedolizumab biologic for maintenance therapy in adults with moderately to severely active ulcerative colitis or Crohn's disease. More news on: Takeda Pharmaceutical Compan...